Handelsbanken Fonder’s Alpine Immune Sciences Inc ALPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-102,000
Closed -$4.04M 1603
2024
Q1
$4.04M Buy
+102,000
New +$3.01M 0.02% 477

Handelsbanken Fonder's ALPN Position: Q2 2024 in Review

Handelsbanken Fonder sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 102,000 shares — an estimated $4.04M sold.

Handelsbanken Fonder first reported a position in ALPN in Q1 2024 and held it in 1 quarter. The position peaked at $4.04M in Q1 2024. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.

  • Handelsbanken Fonder reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
  • Handelsbanken Fonder sold 102,000 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $4.04M.
  • Handelsbanken Fonder first reported a position in Alpine Immune Sciences Inc in Q1 2024 and held it in 1 quarter.
  • Handelsbanken Fonder's Alpine Immune Sciences Inc position peaked at $4.04M in Q1 2024.
  • 0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.

Based on Handelsbanken Fonder's 13F filing for Q2 2024, filed 5 Aug 2024.